Literature DB >> 31531415

Recent trends over time in vascular disease in type 1 diabetes: insights from the Pittsburgh Epidemiology of Diabetes Complications study.

Tina Costacou1, Trevor J Orchard1.   

Abstract

AIMS: To evaluate recent trends, by diagnosis year, in the cumulative incidence of vascular type 1 diabetes (T1D) complications and their risk factors up to 35 years duration.
METHODS: Participants from the Epidemiology of Diabetes Complications study of childhood-onset T1D were categorized into three calendar year onset cohorts: 1965-69, 1970-74, and 1975-80. All-cause, cardiovascular and renal mortality were determined both on the complete cohort (n=440) as well as in the subset with clinical examinations (n=363). Coronary artery disease (CAD, CAD death, myocardial infarction, revascularization, angina and ischemic ECG abnormalities); lower extremity arterial disease (LEAD, abnormal Ankle Brachial Index/amputation/intermittent claudication); distal symmetric polyneuropathy (DSP, clinical exam); cardiac autonomic neuropathy (CAN, abnormal heart rate response to deep breathing); overt nephropathy (ON, albumin excretion rate>200 μg/min) and proliferative retinopathy (PR, fundus photography) were assessed on the subset with clinical examinations.
RESULTS: While all-cause, cardiovascular and renal mortality improved with a more recent diagnosis in the overall cohort, no univariate differences were observed for complications requiring examination (CAD, DSP, CAN, ON), although a borderline trend toward improved complication-free survival with a more recent onset was observed for PR (p=0.06). LEAD incidence showed an anomalous pattern, being highest in the 1975-80 and lowest in the 1970-74 cohort (p=0.009). Allowing for risk factors over time did not materially change these results.
CONCLUSIONS: Despite declines in all-cause, cardiovascular and renal mortality in the total cohort, no improvements were observed in either mortality or complication incidence with a more recent onset in the examined cohort.

Entities:  

Year:  2019        PMID: 31531415      PMCID: PMC6739893          DOI: 10.1097/XCE.0000000000000164

Source DB:  PubMed          Journal:  Cardiovasc Endocrinol Metab        ISSN: 2574-0954


  28 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Heparin--Mn2+ quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples.

Authors:  G R Warnick; J J Albers
Journal:  Clin Chem       Date:  1978-06       Impact factor: 8.327

3.  Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002.

Authors:  Fauzia Mohsin; Maria E Craig; Janine Cusumano; Albert K F Chan; Stephen Hing; Jennifer W Lee; Martin Silink; Neville J Howard; Kim C Donaghue
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

4.  Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study.

Authors:  K Y Forrest; D J Becker; L H Kuller; S K Wolfson; T J Orchard
Journal:  Atherosclerosis       Date:  2000-01       Impact factor: 5.162

5.  Risk factors for progression of distal symmetric polyneuropathy in type 1 diabetes mellitus. Sorbinil Retinopathy Trial Research Group.

Authors:  W G Christen; J E Manson; V Bubes; R J Glynn
Journal:  Am J Epidemiol       Date:  1999-12-01       Impact factor: 4.897

6.  Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.

Authors:  Peter Hovind; Lise Tarnow; Kasper Rossing; Peter Rossing; Stefanie Eising; Nicolai Larsen; Christian Binder; Hans-Henrik Parving
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

7.  Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006.

Authors:  Yoon Hi Cho; Maria E Craig; Stephen Hing; Patricia H Gallego; Myra Poon; Albert Chan; Kim C Donaghue
Journal:  Pediatr Diabetes       Date:  2011-03-24       Impact factor: 4.866

8.  Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).

Authors:  David M Nathan; Bernard Zinman; Patricia A Cleary; Jye-Yu C Backlund; Saul Genuth; Rachel Miller; Trevor J Orchard
Journal:  Arch Intern Med       Date:  2009-07-27

9.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.

Authors:  Ronald Klein; Michael D Knudtson; Kristine E Lee; Ronald Gangnon; Barbara E K Klein
Journal:  Ophthalmology       Date:  2008-11       Impact factor: 12.079

10.  International evaluation of cause-specific mortality and IDDM. Diabetes Epidemiology Research International Mortality Study Group.

Authors: 
Journal:  Diabetes Care       Date:  1991-01       Impact factor: 19.112

View more
  5 in total

1.  Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.

Authors:  Edward J Boyko; Leila R Zelnick; Barbara H Braffett; Rodica Pop-Busui; Catherine C Cowie; Gayle M Lorenzi; Rose Gubitosi-Klug; Bernard Zinman; Ian H de Boer
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

Review 2.  Cardiovascular Disease in Adults with Type 1 Diabetes: Looking Beyond Glycemic Control.

Authors:  Rachel G Miller; Tina Costacou
Journal:  Curr Cardiol Rep       Date:  2022-08-10       Impact factor: 3.955

3.  Skin intrinsic fluorescence scores are a predictor of all-cause mortality risk in type 1 diabetes: The Epidemiology of Diabetes Complications study.

Authors:  Erin L Tomaszewski; Trevor J Orchard; Marquis Hawkins; Baqiyyah N Conway; Jeanine M Buchanich; John Maynard; Thomas Songer; Tina Costacou
Journal:  J Diabetes Complications       Date:  2020-10-23       Impact factor: 2.852

4.  Nine-fold higher risk of acute myocardial infarction in subjects with type 1 diabetes compared to controls in Norway 1973-2017.

Authors:  Maryam Saeed; Lars C Stene; Inger Ariansen; Grethe S Tell; German Tapia; Geir Joner; Torild Skrivarhaug
Journal:  Cardiovasc Diabetol       Date:  2022-04-27       Impact factor: 8.949

5.  Type 1 diabetes, cognitive ability and incidence of cardiovascular disease and death over 60 years of follow-up time in men.

Authors:  Elin Dybjer; Anna K Dahl Aslan; Gunnar Engström; Erik D Nilsson; Katarina Nägga; Peter M Nilsson; Linda B Hassing
Journal:  Diabet Med       Date:  2022-02-13       Impact factor: 4.213

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.